LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-08-19
Case ID: NM_181523.2_c.1126G_A_20260819_053927
Framework: ACMG/AMP 2015
Variant classification summary

NM_181523.2:c.1126G>A

PIK3R1  · NP_852664.1:p.(Gly376Arg)  · NM_181523.2
GRCh37: chr5:67589138 G>A  ·  GRCh38: chr5:68293310 G>A
Gene: PIK3R1 Transcript: NM_181523.2
Final call
VUS
PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
PIK3R1
Transcript
NM_181523.2
Protein
NP_852664.1:p.(Gly376Arg)
gnomAD AF
ClinVar
Pathogenic
OncoKB
Likely Oncogenic
Interpretation summary
Generated evidence synthesis
1
PM2 (Supporting): absent from gnomAD v4.1, total allele frequency below the VCEP's 0.00000132 threshold.
2
Overall classification VUS: point total +1 under the Bayesian framework (Rule3: 0–5 points).
Final determination: Under the PIK3R1 VCEP point-based framework, a total evidence score of 0-5 (Rule3) maps to Uncertain Significance; this variant scores +1 from PM2_Supporting alone, with no other criteria met.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: this is a missense substitution, and the PIK3R1 VCEP PVS1 rule covers only loss-of-function variants.
cspec
PS1 Not assessed Not assessed: no alternate-nucleotide variant producing the same p.(Gly376Arg) change with a pathogenic VCEP classification was identified.
cspec pm5_candidates
PS2 Not assessed Not assessed: no parental genotypes, parentage confirmation, or family-history information was available to establish a de novo occurrence.
cspec
PS3 Not assessed Not assessed: no data showed this variant tested in the VCEP-approved functional assays (lipid/AKT kinase, protein binding, conformational dynamics).
PS4 Not assessed Not assessed: no germline immunodeficiency probands with this variant and evaluable phenotype data were available.
cspec clinvar
PM1 N/A Not applicable: the PIK3R1 VCEP specification designates PM1 out of scope, with no hotspot-based moderate criterion for missense variants.
cspec
PM2 Met Met (Supporting): absent from gnomAD v4.1, total allele frequency below the VCEP's 0.00000132 threshold.
cspec gnomad_v4
PM3 N/A Not applicable: the PIK3R1 VCEP limits PM3 to recessive disorders, and the curated disease context here is autosomal dominant.
cspec
PM4 N/A Not applicable: a single-nucleotide missense change alters one amino acid without changing protein length, so the in-frame-indel/stop-loss rule does not apply.
cspec
PM5 Not assessed Not assessed: no different-amino-acid change at codon 376 with a pathogenic VCEP classification was available to compare.
cspec pm5_candidates
PM6 N/A Not applicable: the VCEP handles de novo evidence through PS2 instead, and no parental-testing data were available.
cspec
PP1 Not assessed Not assessed: no relatives' genotypes, phenotypes, or meioses were documented, so co-segregation could not be counted.
cspec
PP2 N/A Not applicable: the PIK3R1 VCEP specification designates PP2 out of scope for this gene.
cspec
PP3 Not assessed Not assessed: REVEL 0.778 clears the 0.644 threshold, but the required CADD score was unavailable, so the PP3 missense condition could not be confirmed.
cspec revel spliceai
PP4 Not assessed Not assessed: no individual with the germline PIK3R1-related phenotype was documented, so phenotype score and PIK3CD exclusion could not be evaluated.
cspec clinvar
PP5 Not assessed Not assessed: no ClinVar expert-panel pathogenic or likely-pathogenic classification exists for this exact variant.
clinvar
BA1 Not met Not met: absent from gnomAD v4.1, below the VCEP's 0.00316 GrpMax allele-frequency threshold.
cspec gnomad_v4
BS1 Not met Not met: absent from gnomAD v4.1, below the VCEP's 0.000316 GrpMax allele-frequency threshold.
cspec gnomad_v4
BS2 N/A Not applicable: the PIK3R1 VCEP specification designates BS2 out of scope.
cspec
BS3 Not assessed Not assessed: no functional assay data specific to this variant were available, so a benign assay result could not be confirmed.
BS4 Not assessed Not assessed: no affected relatives reported as lacking this variant were documented, so non-segregation could not be assessed.
cspec
BP1 N/A Not applicable: the PIK3R1 VCEP specification designates BP1 out of scope.
cspec
BP2 N/A Not applicable: the PIK3R1 VCEP disallows BP2 because allelic mechanisms and combinatorial variant effects are not fully understood.
cspec
BP3 N/A Not applicable: the PIK3R1 VCEP specification marks BP3 out of scope for this gene.
cspec
BP4 Not met Not met: REVEL 0.778 far exceeds the ≤0.290 ceiling, so the BP4 missense condition fails outright.
cspec revel
BP5 Not assessed Not assessed: no evidence showed this variant in an individual with an independently established alternative molecular cause.
cspec clinvar
BP6 Not assessed Not assessed: no ClinVar expert-panel benign or likely-benign classification exists for this exact variant.
clinvar
BP7 N/A Not applicable: the VCEP's BP7 applies only to synonymous or intronic variants, not this missense change.
cspec
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.